CLINICAL_TRIALS
trial_result
· 2013-07-24
Clinical Trial Update: Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia [Phase 4]
Summary
Phase 4 clinical trial update evaluating switching from oral antipsychotics to long-acting risperidone in people with schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen-Cilag Ltd. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-07-24